2.225USD+0.23%Mkt Cap: 41.08M USDP/E: —Last update: 2026-06-01
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company dev…
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap41.08M USD
Enterprise Value32.69M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.98M USD
Revenue/Share—
Last Price2.225 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4831192020
Valuation
P/E (Trailing)—
P/E (Forward)-0.33
PEG—
EV/EBITDA-0.98
EV/Revenue—
P/S—
P/B0.18
EPS (TTM)-102.01
EPS (Forward)-6.67
52W Range
2.1300% of range1030.00
52W High1030.00 USD
52W Low2.130 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-385.65%
ROA-284.30%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-31.99M USD
CapEx (TTM)15.00K USD
FCF Margin—
FCF Yield-47.39%
Net Debt-8.76M USD
Net Debt/EBITDA0.26
Balance Sheet
Debt/Equity0.00
Current Ratio7.91
Quick Ratio5.63
Book Value/Sh12.56 USD
Cash/Share0.4710 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMay 11, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.18.59M
Float18.59M
Insiders1.30%
Institutions0.64%
Short Interest
Short Ratio0.5d
Short % Float0.23%
Short % Out.0.23%
Shares Short42.59K
Short (prev mo.)21.17K
Technical
SMA 507.006 (-68.2%)
SMA 200133.89 (-98.3%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)82.27K
Avg Vol (10d)64.68K
Technical Indicators
RSI (14)21.8
MACD-1.4906
MACD Signal-1.6611
MACD Hist.+0.1705
BB Upper5.879 USD
BB Middle3.420 USD
BB Lower0.9595 USD
BB Width143.88%
ATR (14)0.6147 USD
Vol Ratio (20d)0.68x